These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20464492)

  • 1. Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?
    Iqbal S; Shah S; Dhar V; Stavropoulos SN; Stevens PD
    Dig Dis Sci; 2011 Jan; 56(1):260-5. PubMed ID: 20464492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes.
    Chahal P; Baron TH; Petersen BT; Topazian MD; Gostout CJ; Levy MJ
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):225-30. PubMed ID: 17912184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.
    Pahk A; Rigaux J; Poreddy V; Smith J; Al-Kawas F
    Dig Dis Sci; 2011 Oct; 56(10):3058-64. PubMed ID: 21487771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis.
    Afghani E; Akshintala VS; Khashab MA; Law JK; Hutfless SM; Kim KJ; Lennon AM; Kalloo AN; Singh VK
    Endoscopy; 2014 Jul; 46(7):573-80. PubMed ID: 24830399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry.
    Sahar N; Ross A; Lakhtakia S; Coté GA; Neuhaus H; Bruno MJ; Haluszka O; Kozarek R; Ramchandani M; Beyna T; Poley JW; Maranki J; Freeman M; Kedia P; Tarnasky P;
    Dig Endosc; 2019 May; 31(3):299-306. PubMed ID: 30506606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial.
    Fujisawa T; Kagawa K; Ochiai K; Hisatomi K; Kubota K; Sato H; Nakajima A; Matsuhashi N
    J Clin Gastroenterol; 2016 Mar; 50(3):e30-4. PubMed ID: 26280707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.
    Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y; Ogawa T
    J Gastroenterol; 2010 Nov; 45(11):1183-91. PubMed ID: 20607310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of physician practices on prophylactic pancreatic stents.
    Brackbill S; Young S; Schoenfeld P; Elta G
    Gastrointest Endosc; 2006 Jul; 64(1):45-52. PubMed ID: 16813802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial.
    Zolotarevsky E; Fehmi SM; Anderson MA; Schoenfeld PS; Elmunzer BJ; Kwon RS; Piraka CR; Wamsteker EJ; Scheiman JM; Korsnes SJ; Normolle DP; Kim HM; Elta GH
    Endoscopy; 2011 Apr; 43(4):325-30. PubMed ID: 21455872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial.
    Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M
    Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.